Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus

Arthritis Rheum. 1997 Sep;40(9):1703-11. doi: 10.1002/art.1780400921.

Abstract

Objective: To study the in vitro effect of testosterone on anti-DNA antibody production in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE) in order to elucidate its regulatory role in SLE.

Methods: PBMC from SLE patients were cultured with testosterone. IgG anti-double-stranded DNA (anti-dsDNA) antibody, total IgG, and cytokine activity in the supernatants were measured by enzyme-linked immunosorbent assay.

Results: Testosterone suppressed both IgG anti-dsDNA antibody and total IgG production in PBMC from SLE patients. Antibody production in B cells was also suppressed by testosterone, although the magnitude of its effect on B cells was lower than that on PBMC. Interleukin-6 (IL-6) partially restored the testosterone-induced decrease in antibody levels in PBMC. Testosterone reduced IL-6 production in monocytes.

Conclusion: These results suggest that testosterone may directly suppress anti-DNA antibody production in PBMC from SLE patients by inhibiting B cell hyperactivity and, indirectly, by down-regulating IL-6 production in monocytes. These results support the therapeutic effects of testosterone on SLE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Antinuclear / biosynthesis*
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Interleukins / biosynthesis
  • Interleukins / pharmacology
  • Lupus Erythematosus, Systemic / immunology*
  • Male
  • Middle Aged
  • Monocytes / drug effects
  • Monocytes / immunology*
  • Testosterone / pharmacology*

Substances

  • Antibodies, Antinuclear
  • Interleukins
  • Testosterone